Stefan Pfennigsdorf

Statistics

Publications

Citations

H-Index

Active since

1994

Affiliations

Polo d’Innovazione di Genomica(Current)

Allergan (United Kingdom)

Stefan Pfennigsdorf is an author at Polo d’Innovazione di Genomica specializing in ocular disease, ocular hypertension treatment, and ocular tolerability.

Publications per year

1994–2016

Publications

Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice

L. E. Pillunat, Peter Eschstruth, Stefan Häsemeyer et al. · Clinical ophthalmology · 2016 · 20 citations · Full text

Health Professions, Ophthalmology, Pharmacotherapy +16

Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension

Stefan Pfennigsdorf, Ramez, von Kistowski et al. · Clinical ophthalmology · 2012 · 18 citations · Full text

Health Professions, Ophthalmology, Pharmacotherapy +14

A combined analysis of five observational studies evaluating the efficacy and tolerability of bimatoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension

Stefan Pfennigsdorf, De Jong, Makk et al. · Clinical ophthalmology · 2013 · 14 citations · Full text

Health Professions, Ophthalmology, Pharmacotherapy +15

On the mechanism of action of phenylephrine in rat atrial heart muscle

Ulrich Jahnel, Erik Duwe, Stefan Pfennigsdorf et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1994 · 13 citations

Medicine, Pharmacology, Physiology +9

1–4 of 4